Doxorubicin Resistance in Breast Cancer is Driven by Light at Night Induced Disruption of the Circadian Melatonin Signal

Chemotherapeutic resistance, particularly to doxorubicin (Dox), represents a major impediment to successfully treating breast cancer and is linked to elevated tumor metabolism and tumor over-expression and/or activation of various families of receptor- and non-receptor-associated tyrosine kinases. D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pineal Res
Main Authors: Xiang, Shulin, Dauchy, Robert T., Hauch, Adam, Mao, Lulu, Yuan, Lin, Wren, Melissa A., Belancio, Victoria P., Mondal, Debasis, Frasch, Tripp, Blask, David E., Hill, Steven M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490975/
https://ncbi.nlm.nih.gov/pubmed/25857269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jpi.12239
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados